A gene silencing-based approach to tackle fatty liver disease

Mol Ther Methods Clin Dev. 2024 Feb 9;32(1):101198. doi: 10.1016/j.omtm.2024.101198. eCollection 2024 Mar 14.

Authors

Pavel Strnad¹, Christina Schrader¹, Nicola Brunetti-Pierri^{2

3

4}

Affiliations

¹ Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
² Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy.
³ Department of Translational Medicine, Federico II University, Naples, Italy.
⁴ Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, Naples, Italy.

No abstract available

Publication types

News